Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

Dos D. Sarbassov

Discovered rictor and defined mTOR Complex 2

Postdoc, Whitehead Institute/MIT (Sabatini lab) · Dept. of Molecular & Cellular Oncology, MD Anderson Cancer Center · now Professor of Biology, Nazarbayev University, Kazakhstan

Faculty profile, Nazarbayev University ↗

Dos D. Sarbassov

Dos Sarbassov trained as a postdoc in David Sabatini's lab, where he identified rictor (rapamycin-insensitive companion of mTOR), the protein that defines mTOR Complex 2 — a second mTOR machine, distinct from mTORC1, that is largely insensitive to short-term rapamycin treatment and instead controls the actin cytoskeleton.

Sarbassov then showed that mTORC2 directly phosphorylates Akt/PKB on serine 473, identifying mTORC2 as a missing kinase in the insulin-signalling pathway with direct relevance to cancer and metabolic disease. He continued this line of work as a faculty member in the Department of Molecular and Cellular Oncology at MD Anderson Cancer Center.

The timeline below follows Sarbassov's contributions gathered in this Atlas.

Milestones in the Atlas

YearEvidenceStudy
2002 M mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery KIM2002 Discovery of Raptor as the defining partner of mTOR in mTORC1. This is the paper that gives mTORC1 its identity: Raptor is the scaffold that lets mTOR find and phosphorylate its targets (S6K1), and the complex is stabilized under starvation. Companion paper to Hara 2002.
2003 M GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR KIM2003 Discovered mLST8 (GbetaL), the third core subunit that clamps onto mTOR's kinase domain and stabilizes the complex. It fine-tunes how tightly Raptor holds mTOR in response to nutrients - a small but essential cog that later turned out to be especially critical for the mTORC2 complex.
2004 M Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton SAR2004 Discovers rictor and defines mTOR Complex 2, a rapamycin-insensitive mTOR machine distinct from mTORC1.
2005 M Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex SAR2005 Shows mTORC2 directly phosphorylates and activates Akt/PKB, wiring mTOR into insulin signalling.
2006 M Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB SAR2006 Shows prolonged rapamycin treatment can also disassemble mTORC2, explaining some of the drug's off-target effects.

← All researchers